Attached files
| file | filename |
|---|---|
| EX-1.1 - EX-1.1 - Intra-Cellular Therapies, Inc. | d652050dex11.htm |
| EX-23.2 - EX-23.2 - Intra-Cellular Therapies, Inc. | d652050dex232.htm |
| EX-5.1 - EX-5.1 - Intra-Cellular Therapies, Inc. | d652050dex51.htm |
| S-1/A - AMENDMENT NO.1 TO FORM S-1 - Intra-Cellular Therapies, Inc. | d652050ds1a.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 19, 2013, in Amendment No. 1 to the Registration Statement (Form S-1 No. 333-193313) and related Prospectus of Intra-Cellular Therapies, Inc. for the registration of 5,750,000 shares of its common stock.
/s/ Ernst & Young LLP
McLean, VA
January 23, 2014